
Testosterone Therapy for Women: What the Evidence Supports
Elizabeth Vogstrom, PA-C
evoyouthful Clinical Team
Testosterone therapy for women: what it can treat, what it can't, dosing and monitoring, side effects, and how to get a careful evaluation in Wayzata, MN.

Testosterone therapy for women has one well-supported use: helping postmenopausal women whose sexual desire has dropped enough to cause distress. Beyond that, the evidence is still limited. No testosterone product is FDA-approved for women in the U.S., so safe treatment depends on a thorough evaluation, a low dose and follow-up lab work. At evoyouthful in Wayzata, our hormone care starts with a detailed assessment, because the right answer for you depends on your symptoms, your labs and your health history.
TL;DR
- Best-supported benefit: In postmenopausal women with low sexual desire that causes distress, physiologic-dose testosterone improves sexual function. On average, that is about one additional satisfying sexual event per month.
- Not proven for: energy, mood, memory, bone density, muscle or weight loss. Research on these is either insufficient or still emerging.
- No blood-level diagnosis: No testosterone level diagnoses “low T” in women. Labs set a baseline and keep treatment in a safe range.
- Safety: Short-term studies at physiologic doses found no serious adverse events. Long-term data beyond two years are not available.
- Next step: A full hormone evaluation comes first, since menopause symptoms often have several causes.
Table of Contents
- What testosterone does in a woman’s body
- What testosterone therapy can help with
- What testosterone does not reliably treat
- How the evaluation works
- Forms, dosing and monitoring
- Risks, side effects and who should be cautious
- Why many doctors hesitate
- Our perspective
- Hormone evaluation in Wayzata
- FAQ
- Sources
What testosterone does in a woman’s body
Women make testosterone in the ovaries and adrenal glands, and it does more than drive libido. The 2019 Global Consensus Position Statement describes it as a metabolic, vascular and reproductive hormone that plays a role in female sexual function. Levels decline gradually through your 20s, 30s and 40s, which means the drop is not a sudden event at menopause.
People often ask about the signs of low testosterone in women. Reduced sexual desire, less arousal and a flatter sense of pleasure are the symptoms the research ties to testosterone. Fatigue, low mood, brain fog and weight changes also show up in midlife, but they overlap with estrogen and progesterone shifts, thyroid problems, sleep disruption and stress. That overlap is why a symptom list alone cannot tell you whether testosterone is the missing piece.
There is also a lab limitation. The same consensus statement notes that no androgen cutoff separates women with and without sexual dysfunction. A “low” result on a lab report is not a diagnosis by itself. Your clinician connects the number to your symptoms and your history.
What testosterone therapy can help with
Sexual desire after menopause
The diagnosis behind most of the research is hypoactive sexual desire disorder (HSDD): a persistent drop in sexual desire that bothers you. For postmenopausal women with HSDD, the consensus statement finds that physiologic-dose testosterone improves sexual function, including desire, arousal, orgasm, pleasure, responsiveness and sexual distress, compared with placebo or another comparison treatment.
The size of the effect deserves a realistic description. A 2019 meta-analysis of 36 randomized trials with 8,480 participants reported a mean increase of 0.85 satisfying sexual events, with a 95% confidence interval of 0.52 to 1.18. In plain terms, that is roughly one more satisfying sexual experience a month on average. Some women notice a meaningful change in desire and connection. Others notice little, which is why a defined trial period matters (more on that below).
Who is an established candidate
The 2021 guideline from the International Society for the Study of Women’s Sexual Health (ISSWSH) identifies a postmenopausal woman with HSDD after a formal biopsychosocial assessment as the established candidate. “Biopsychosocial” means your clinician looks at physical health, medications, mood, stress, relationship factors and hormones together. The guideline notes limited data for selected premenopausal women in the later reproductive years.
This is a good moment for a quick self-check:
- Has your desire changed noticeably, and does that change bother you?
- Have you ruled out common contributors such as poor sleep, new medications, vaginal dryness or relationship strain?
- Are you postmenopausal, or have you had a conversation with a clinician about hormone therapy for menopause symptoms?
If you answered yes to the first and are unsure about the others, an evaluation is the right place to start.
What testosterone does not reliably treat
This is the part of the “benefits” conversation that gets blurred online. The consensus statement finds that evidence is insufficient for cognition, wellbeing, mood, bone density, lean mass, body fat or muscle strength. A 2026 review adds that research on possible vascular, genitourinary and other physiologic effects remains emerging and has not yet changed guideline-level practice.
A few practical points follow from that:
- Weight loss: The 2019 meta-analysis found an overall increase in weight with testosterone and no reported effect on body composition. If weight is your goal, a physician-supervised plan built for that purpose is the better fit, and our medical weight loss program is designed around it.
- Bone health: Protecting your skeleton after menopause has its own evidence base. Reading about bone density after menopause shows how different strategies are being studied for that goal.
- Mood and memory: Midlife brain fog is often tied to estrogen timing and formulation. Our article on midlife HRT for brain fog covers that, and menopause, mood and muscle explains how hormones shape the way you feel in your body.
If your main concerns are hot flashes, sleep or mood, the conversation usually begins with estrogen and progesterone rather than testosterone. Our guide to BHRT for menopause walks through what the evidence says.
How the evaluation works
Because no level diagnoses a deficiency, the evaluation is mostly about understanding you. The 2021 ISSWSH guideline calls for assessing contributing factors and obtaining a baseline total testosterone for monitoring, not for diagnosis. A 2025 U.S. Department of Veterans Affairs clinical summary adds that testosterone testing does not diagnose HSDD or predict response. It recommends baseline total testosterone, sex hormone-binding globulin, liver function tests and a lipid panel before treatment, with other tests as clinically indicated.
Sex hormone-binding globulin (SHBG) is a protein that carries hormones in your blood and affects how much is available to your tissues. The liver and lipid tests establish a safety baseline you can compare against later.
A good first visit usually covers:
- Your symptoms, when they began and how much they affect daily life
- Your medications, supplements, sleep, stress and relationship context
- Your menopause status and any current or past hormone therapy
- A complete lab panel (our guides to a comprehensive hormone panel and a hormone panel testing checklist explain what each marker tells you)
- A shared decision on whether treatment makes sense and what success would look like
If libido is your central concern, it is also worth knowing there are other approaches. We cover one of them in PT-141 for libido.
Forms, dosing and monitoring
Why dosing is careful
In the U.S., no testosterone product for women is approved. Clinicians therefore use male products off label, which means for a purpose the FDA has not specifically approved, with careful dosing and monitoring. The ISSWSH guideline says male transdermal (through the skin) products may be used cautiously at appropriately reduced female doses when no authorized female formulation is available.
As one example of what “reduced” means, the 2025 VA summary describes a starting dose of 5 mg daily, one-tenth of a tube of 1% male gel, with a possible increase to 10 mg if needed. That is an off-label example, not a universal prescription, and your own dose should be set by your clinician. The same summary advises applying gel to the back of the calf, upper outer thigh or buttock, and preventing transfer to children, pets or a female partner.
The 2019 consensus statement recommends against oral testosterone because of adverse effects on cholesterol and other lipids, and against any preparation that pushes levels above the physiologic range. The target is to stay within the normal premenopausal range for women, not to chase a higher number.
The monitoring schedule
The ISSWSH guideline lays out a clear rhythm: check testosterone at baseline, 3 to 6 weeks after starting and after any dose change, then every 4 to 6 months once you are stable. At each check, your clinician looks at two things: whether you feel a benefit and whether there are signs of androgen excess. The guideline also says to stop by six months if there is no meaningful benefit. That built-in decision point protects your time and budget.

Risks, side effects and who should be cautious
At physiologic doses, the common effects are mild. They include acne and increased facial or body hair. Higher-than-intended exposure can cause voice deepening and androgenic hair loss, and oral forms can affect lipids, according to the ISSWSH guideline. This is why follow-up labs matter as much as the first prescription.
On the larger safety question, the consensus statement reports that short-term trials found no serious adverse events at physiologic doses. It also says women at high cardiometabolic risk were generally excluded from those studies and that safety data beyond 24 months are unavailable. Long-term safety has not been established, particularly for higher-risk groups, and the guideline advises caution with hormone-sensitive breast cancer.
Tell your clinician if you have:
- A history of breast or other hormone-sensitive cancer
- Heart disease, high cholesterol, diabetes or liver disease
- Pregnancy, plans for pregnancy or breastfeeding
- Unexplained hair growth, acne or voice changes before you start
These details shape whether treatment is appropriate at all, and any decision involving them should be made together with your prescribing clinician and, where relevant, your oncologist or cardiologist.
Why many doctors hesitate
If your primary care doctor was cautious when you raised the topic, there are understandable reasons. There is no FDA-approved product for women, so every prescription is off label. The strongest evidence covers one narrow indication. Long-term safety data are limited. Many clinicians also have little training in female hormone dosing. None of this means your symptoms are not real. It means the right setting is one where a clinician has hormone expertise and a structured monitoring plan.
Our perspective
Women often arrive at our clinic after months of being told that what they feel is simply “part of aging.” Our approach is to take the whole picture seriously: symptoms, sleep, stress, labs and goals.
Testosterone is one piece of hormone health, and for the right patient it can matter. We think the most useful thing we can offer is a plan built on data, with a clear check-in schedule so you always know whether what we are doing is working for you.
Our team combines aesthetics and regenerative medicine, so we can look at how you feel and how you look together, and tailor each plan to you.
Elizabeth Vogstrom, PA-C
Hormone evaluation in Wayzata
The clinic is led by an award-winning, advanced BHRT-certified Physician Assistant with more than 20 years of medical aesthetics experience, and our treatment plans are personalized and data-driven. If you live in Wayzata, Minnetonka, Plymouth, Eden Prairie or the surrounding lake communities, you can start with a consultation about your symptoms and goals through our bioidentical hormone replacement therapy services.

Our BHRT membership option can also be discussed at your visit, along with the other treatments we offer for skin, energy and vitality.
FAQ
What are the benefits of testosterone for women?
The best-supported benefit is improved sexual function in postmenopausal women with distressing low desire. Studies show gains in desire, arousal, orgasm and pleasure. Evidence for mood, memory, bone, muscle and body composition is insufficient or still emerging.
Can women take testosterone to lose weight?
The research does not support it. A 2019 meta-analysis found an overall increase in weight and no reported effect on body composition. A supervised weight management plan is a better route to that goal.
How long before I know if it is working?
Guidelines call for a blood test 3 to 6 weeks after starting, then regular follow-up. Treatment is generally stopped if there is no meaningful benefit by six months, so you have a clear point to judge results.
Is testosterone therapy safe for women?
Short-term trials at physiologic doses found no serious adverse events, but data beyond 24 months are not available and higher-risk women were generally excluded. Safety depends on staying within the premenopausal range, which is why monitoring is essential. Discuss your own history with your clinician first.
Sources
- Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019)
- Safety and efficacy of testosterone for women: a systematic review and meta-analysis (2019)
- Testosterone in Women: Clinical Evidence and Practice (2026)
- ISSWSH guideline on testosterone therapy for women with HSDD (2021)
- U.S. Department of Veterans Affairs, Transdermal Testosterone (Off-Label) for HSDD clinical summary (March 2025)
Recommended
Ready to Start?
Schedule a Consultation
Have questions about what you just read? Our team is here to help.
